Recruiting

WAVwatch 2.0

Sponsor:

Efforia, Inc

Code:

NCT07281989

Conditions

Stress

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Accepted

Interventions

WAVWatch 2.0

Study Details

Brief summary:

Sound Off Stress Study seeks to discover if WAVwatch 2.0-a sleek, wearable sound frequency device-can support mental harmony.

Conditions

Stress

Study ID

NCT07281989

Start date

Aug 25, 2025

Status verified date

Dec, 2025

Completion date

Aug 25, 2026

Anticipated

Primary completion date

Aug 25, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Can read and understand English.
  • US resident.
  • Willing and able to follow the requirements of the protocol.

Exclusion Criteria:

  • Individuals with skin sensitivities
  • Individuals with auditory conditions
  • Individuals with severe anxiety or mental health disorders
  • Pregnancy
  • Individuals prone to irritation or frustration

Study Design

Enrollment

100 participants

Anticipated

Intervention Model

Single group

Primary purpose

Health Services Research

Interventions and Outcome Measures

Arms

experimental: Single arm where participants act as their own control

Single arm where participants act as their own control

Interventions

WAVWatch 2.0

The WAVwatch 2.0, a wrist-worn device intervention, leverages 'calming' frequencies to reduce stress and non-clinically relevant anxiety, aligning with scientific evidence supporting sound therapy's potential.

Primary outcome measure

  • Perceived Stress Scale (Past Week Version) [ Time Frame: Change from baseline (Day 1-3) in perceived stress levels at 4 weeks after the start of the intervention (Day 27-33) ]
  • General Anxiety Disorder (GAD-7) [ Time Frame: Change from baseline (Day 1-3) in anxiety severity at 4 weeks after the start of the intervention (Day 27-33) ]
  • NIH Toolbox® Item Bank v3.0 - General Life Satisfaction (Ages 18+) [ Time Frame: Change from baseline (Day 1-3) in general life satisfaction at 4 weeks after the start of the intervention (Day 27-33) ]
  • Depression, Anxiety and Stress Scales (DASS-21) Survey [ Time Frame: Change from baseline (Day 1-3) in depression, anxiety, and stress levels at 4 weeks after the start of the intervention (Day 27-33) ]

Central Contacts and Locations

Central contacts

Matthew Amsden

646-679-2479help@efforia.com

Locations

Efforia

Recruiting

New York, New York, United States, 10003

Contacts

Matthew Amsden

(646) 679-2479help@efforia.com

More Information

Sponsor

Efforia, Inc

Last update posted

Dec 23, 2025

Last verified

Dec, 2025

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Efforia, Inc on 2025-12-23.